Brief: Quince Therapeutics Board Rejects Proposal From Echo Lake Capital

IRulya Therapeutics

11/04/2023 12:25

April 11 (Reuters) - Quince Therapeutics Inc  QNCX.O :
    * QUINCE THERAPEUTICS BOARD OF DIRECTORS UNANIMOUSLY REJECTS
UNSOLICITED PROPOSAL FROM ECHO LAKE CAPITAL
    * QUINCE THERAPEUTICS BOARD OF DIRECTORS UNANIMOUSLY REJECTS
UNSOLICITED PROPOSAL FROM ECHO LAKE CAPITAL
    * QUINCE THERAPEUTICS - BOARD UNANIMOUSLY REJECTED
UNSOLICITED
PROPOSAL IT RECEIVED FROM ECHO LAKE CAPITAL TO ACQUIRE QUINCE
FOR $1.60 PER SHARE IN CASH
    * QUINCE THERAPEUTICS - FOLLOWING CAREFUL REVIEW AND
EVALUATION,
QUINCE BOARD CONCLUDED THAT ECHO LAKE CAPITAL'S PROPOSAL
UNDERVALUES CO
    * QUINCE THERAPEUTICS - QUINCE BOARD CONCLUDED THAT ECHO
LAKE
CAPITAL'S PROPOSAL IS NOT IN BEST INTEREST OF QUINCE AND ITS
SHAREHOLDERS

Source text for Eikon:  ID:nBw1x4sG4a 
Further company coverage:  QNCX.O 

 ((Reuters.Briefs@thomsonreuters.com;))